ArF Excimer Laser Debrides Burns without Destruction of Viable Tissue: A Pilot Study

According to the American Burn Association, each year in the United States, 40,000 cases require hospitalization with an estimated annual expenditure of over $1 billion in associated costs. Burns are dynamic injuries that progress over time, with extension of depth and size of the burn. Recent investigations at Stony Brook University using tangential debridement, demonstrate that early removal of burn eschar can promote healing. However, the central face, ears, hands and feet, enveloped by thin skin, provide a challenging environment for tangential debridement to experienced burn surgeons. Furthermore, tangential debridement often sacrifices viable tissue and impedes optimal engraftment. Here, data from a pilot study demonstrates that ArF excimer laser irradiation removes burn eschar and enhances healing at 10 days post-burn. ArF excimer laser debridement is self-terminating and preserves underlying and adjacent perfused tissue. Potentially, this modality would be ideal for the complex curvilinear structures of the body.

By: Atulya Prasad , Katarzyna M. Sawicka , Kelly B. Pablo , Lauren K. Macri , Jerome Felsenstein , James J. Wynne , Richard A. F. Clark

Published in: RC25590 in 2016

LIMITED DISTRIBUTION NOTICE:

This Research Report is available. This report has been submitted for publication outside of IBM and will probably be copyrighted if accepted for publication. It has been issued as a Research Report for early dissemination of its contents. In view of the transfer of copyright to the outside publisher, its distribution outside of IBM prior to publication should be limited to peer communications and specific requests. After outside publication, requests should be filled only by reprints or legally obtained copies of the article (e.g., payment of royalties). I have read and understand this notice and am a member of the scientific community outside or inside of IBM seeking a single copy only.

rc25590.pdf

Questions about this service can be mailed to reports@us.ibm.com .